PMS & Menstrual Health Supplements Market

PMS & Menstrual Health Supplements Market Size and Share Analysis

The global PMS & menstrual health supplements market is anticipated to increase from US$24.2 Bn in 2024 to US$35.6 Bn by the end of 2031. The market is expected to expand at a CAGR of 5.7% during the forecast period from 2024 to 2031.

Key Highlights of the Market

• Premenstrual syndrome (PMS) including physical and psychological symptoms that are clinically significant during the luteal phase of the menstrual cycle causing severe distress and functional impairment.
• Changes in the food consumption patterns (such as high sugar) are shaping the market performance.
• Technological advancements are driving market growth.
• PMS & menstrual health wellness is a highly competitive industry, characterized by global and regional players.
• Companies are claiming to have products that cure or at least reduce the symptoms of PMS. However,  most of these supplements have not been checked or proven to truly help.
• Asia’s PMS & menstrual health supplements market is expected to have significant contribution with increasing health awareness amongst women. This market trend is expected to continue, with the capsules/tablets segment maintaining its position at the forefront.

Attributes	Key Insights
Market Size (2024E)	US$24.2 Bn
Projected Market Value (2031F)	US$35.6 Bn
Forecast Growth Rate (CAGR 2024 to 2031)	5.6%
Historical Growth Rate (CAGR 2019 to 2023)	5.4%

Region-wise Analysis

North America to Take Charge in the Market

Region	Market Share through 2024
North America	39%

In North America, there is a strong focus on research and development to enhance the effectiveness of nutritive supplements for managing premenstrual syndrome. Companies like Looni in the US have launched products aimed at hormone balance to help lower mood swings and irritations associated with PMS. 

The rise of e-commerce and direct-to-consumer sales channels has also contributed towards the growth of the PMS & menstrual health supplements market, making it easier for consumers to access these products.

Category-wise Analysis

Combined Nutritional Supplements Contribute Highest Revenue Share

Category	Market Share through 2022
Combined Nutritional Supplements	50%

Combined nutritional supplements captured a dominant revenue share of over ~50% in 2022. Certain vitamins and minerals must be taken together to relieve PMS symptoms. Effective combinations include magnesium and vitamin D3, omega 3 and vitamin E, and magnesium and zinc.

Tablet/Capsule Formulations at the Forefront

Category	Market Share through 2022
Table/ Capsule Formulation	45%

The tablets and capsules are the main formulation types in the PMS & menstrual health supplements market. Their dominance is attributed to the convenience, ease of consumption, and precise administration they offer, making them the preferred choice for consumers seeking menstrual health supplements. 

Market Overview and Trend Analysis

Recently, there has been a significant upsurge in understanding surrounding women’s health. A crucial player in this movement is the increasing market for food supplements made-to-order to address the needs of women exclusively, especially those related to premenstrual syndrome (PMS) and total well-being. This mushrooming PMS nutraceuticals industry reflects the cultural shift towards comprehensive self-care and a proactive approach to health.

According to a study by Expansion Consulteam carried out in August 2022, around 60% of women of childbearing age globally report PMS symptoms, of which 64% report that PMS impedes with their daily lives. Nearly, 64% experience anxiety or mood swings and 57% experiencing tiredness.

With globally increasing awareness about PMS & menstrual health supplements market, countries like China, India and Japan are leading the demand due to an increase in the number of women experiencing the need to soothe the effects of the symptoms observed during PMS.

The growing demand for Women’s health and PMS nutraceuticals can be accredited to various factors, including a deepened awareness of the significance of nutrition in managing hormonal imbalances and supporting total health.

Women today are more up to date about their bodies and seek products that line up with their specific needs. Younger generations such as gen z and millennials have incorporated an improved openness in relation to menstrual wellbeing.

In addition to the use of reliable sites, social media and period tracker apps (Flow, Glow, Clu, Eve, Etc.) to stay updated, they influence this technology to manage their emotional well-being. The move towards pre-emptive healthcare has led to a rise in the use of dietary supplements as a proactive measure to address apprehensions before they intensify.

Historical Growth and Course Ahead

Research has been focusing on finding out effective treatments/ preventive mechanisms for PMS and menstrual wellbeing. Most women of generative age have one or more emotional or physical symptom in the premenstrual phase of the menstrual cycle.

The symptoms are trivial, but 5 to 8% have moderate to severe symptoms that are associated with significant distress or functional impairment. In early medical reports about this issue, clinically significant premenstrual symptoms were named premenstrual tension (PMT) or premenstrual syndrome (PMS).

AbbVie in cooperation with Neurocrine Biosciences, Inc., broadcasted that the US Food and Drug Administration (FDA) approved ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules), with a treatment duration of up to 24 months. ORIAHNN is the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. ORIAHNN was expected to be available in the US by the end of June 2020

While more research, funding and innovation is necessary, corporations and scientists are taking a stand to seal the market and knowledge gap. Fresh research shows following a gut-friendly diet may ease menopause issues. Manufacturers in the PMS & menstrual health supplements market are also launching products in different formats, targeting PMS, nausea, bloating, cramping and irritability.

Nearly 90% of people who menstruate experience premenstrual symptoms. Moreover, there are platforms offered to help access for women to talk over body literacy and areas usually left in the dark, such as pregnancy loss, vaginal discharge, period sex and endometriosis.

COVID-19 Vaccination and Menstrual Changes

• Anecdotal Reports: There have been anecdotal reports of menstrual changes after COVID-19 vaccination. Some people noticed alterations in menstrual duration, frequency, regularity, and even heavier bleeding or worsened PMS.
• Research Gap: Unfortunately, most large-scale COVID-19 studies (including vaccine trials) did not specifically ask about menstruation. So, we’re still figuring out how many women experienced these changes, how long they persisted, and whether they’re directly related to COVID-19 or other factors.
• Recent Research: A study supported by the National Institutes of Health (NIH) found a small, temporary increase in menstrual cycle length after COVID-19 vaccination. However, there was no increase in the number of bleeding days.

Market Growth Drivers

Increased PMS Related Awareness

There is an increase in the understanding of premenstrual syndrome (PMS) and its impact on female health, which drives the demand for supplements.  Recent studies have utilized the Global Burden of Disease (GBD) Study 2019 dataset to consider the distributional trends in PMS burden and prevalence across various regions and sociodemographic index (SDI) categories.

The findings indicate that while the global incidence and disability-adjusted life years (DALYs) of PMS showed a declining trend in 2019, PMS remains a prevalent health concern for women worldwide.

It is important to note that regions with medium–low SDI had the greatest burden of PMS, with South Asia exhibiting the highest age-standardized incidence rates. On the other hand, high-income North American states presented the fastest upward trends in age-standardized DALY rates. At the national level, 107 nations exhibited a decreasing trend in PMS incidence, while 97 nations showed an increasing trend, with the US presenting the greatest increase.

Another study highlighted that over the past few decades, the global prevalent cases of PMS have grown significantly from 652.5 million in 1990 to 956.0 million in 2019, representing a 46.5% increase. This underscores the importance of addressing preventive measures and treatment, considering regional and national differences in PMS to develop effective and targeted health policies.

Studies have shown a connection between lifestyle choices, such as diet, and the intensity of PMS symptoms, leading to a higher intake of health supplements. Apart from dietary habits, stress levels, urbanization and information access and e-commerce accessibility are some of the lifestyle factors playing an important role in the PMS & menstrual health supplements market growth.

Pharmaceutical R&D Advancements

Advancements in pharmaceutical research and the development of new inventions have contributed to the growth of the PMS & menstrual health supplements market. Some key trends are data-driven and AI algorithms (used to provide personalized supplement recommendation), wearable technology (tracking menstrual cycles and symptoms, allowing for tailored supplement suggestions), innovation formulations (companies are exploring novel elements like plant extracts, minerals, probiotics and vitamins known for its competence to ease PMS syndrome).

Impact of COVID-19 and E-commerce

The pandemic has increased awareness concerning physical, mental, and emotional health, influencing the market completely as people seek supplements to manage PMS. The COVID-19 pandemic has led to a heightened awareness of physical and mental health, which, along with the convenience of e-commerce due to accessibility of supplements through online channels, has made health supplements more accessible.

Growing Focus on Research and Development

Research and development are being severely invested in by manufacturers and healthcare providers to develop successful and safe supplements tailored to fulfil the specific needs of women at different phases of their menstrual cycles. Companies like Looni, and Power Gummies are aggressively developing procedures to help manage premenstrual syndrome with ingredients such as chasteberry, vitamin C, passionflower, and citrus bioflavonoids.

Mounting Prevalence of PCOS

The growth of the PMS & menstrual health supplements market is also supported by the increasing prevalence of conditions like PCOS, and other hormonal disorders. The increasing frequency of PCOS, which affects an estimated 8-13% of women of reproductive age globally, is increasing the demand for menstrual health supplements. These supplements are formulated to alleviate various menstrual symptoms, including those associated with PCOS.

However, challenges such as the lack of regulatory oversight and standardization, and limited scientific evidence supporting supplement effectiveness, can affect market dynamics.

Factors Impeding the Market

Lack of Product Differentiation

With exceedingly competitive market, standing out with exclusive product offerings is challenging. With many brands offering similar products, it can be difficult for companies to differentiate and capture market share. This is a shared issue in markets with a high level of opposition and can limit growth by making it harder for consumers to identify exclusive value propositions among products.

However, companies may need to emphasize on innovation and clearly sharing benefits of their products to overcome the hurdle of narrow differentiation. Additionally, the market faces other challenges such as strict regulations and the need for more logical evidence to support the effectiveness of some products.

Limited Scientific Validation

Many products lack dependable empirical support, which affects the market negatively due to unsatisfactory clinical research and scientific data. The lack of robust enquiry and regulatory oversight can lead to consumer scepticism and safety concerns, potentially hindering further growth.

Increased cognizance and acceptance of natural women’s health approaches are driving demand for products that alleviate symptoms and enhance menstrual well-being. Nevertheless, it is a challenge to provide substantial scientific evidence to support the effectiveness of these supplements.

Availability of Alternative Treatments

The presence of many alternative treatments for menstrual health can limit the market for supplements. The availability of unconventional treatments seems to be influencing the PMS & menstrual health supplements market growth.

The global complementary and alternative medicine market, which comprises of several interventions like botanicals, mind and body healing, and external energy therapies, was valued at US$144.68 billion in 2023 and is projected to grow at a CAGR of 25.3% from 2024 to 2030.

This evolution is driven by factors such as improved awareness, disposable income, and administrative initiatives stimulating complementary and alternative medicine (CAM).

Opportunities for PMS and Menstrual Supplement Companies

Accelerating Consumer Demand

There is an increasing awareness and acceptance of menstrual health issues, leading to higher demand for products that lessen symptoms associated with PMS and promote overall menstrual health.

A steady surge in consumer demand and a promising future for companies operating in this space. It is a clear signal for businesses to invest in the PMS & menstrual health supplements market, considering the growing occurrence of PMS and menstrual disorders, technological advancements in supplement formulation, and the rising prevalence of conditions like dysmenorrhea and premenstrual dysphoric disorder (PMDD).

Greater Emphasis on R&D Innovation

Companies are focusing on research and development for boosting the effectiveness of nutritional supplements. For example, Power Gummies, a leader in India has developed a formula for PMS relief that includes chasteberry, vitamin C, passionflower, and citrus bioflavonoids.

The demand for herbal and natural supplements is on the rise, as consumers pursue holistic health solutions. Educational resourcefulness and targeted marketing are helping to increase consumer knowledge and drive sales.

Demand for menstrual hygiene products is also pouring the growth of the PMS and menstrual health supplement market. Companies are gradually considering cultural and diversity factors in their product offerings.

Competitive Landscape Analysis

The PMS & menstrual health supplements market is highly competitive, characterized by the presence of bountiful global and regional players. Key market participants include large pharmaceutical companies, specialized supplement manufacturers, and evolving start-ups focused on women's health.

Companies are likely to focus on pilot strict regulations and agreement processes, which can be challenging but also ensure the safety and efficacy of supplements. Regulations can ensure the safety, efficacy, and quality of supplements, which can increase consumer trust and drive market growth.

Key Industry Developments

• In Aug 2021, Looni, a US-based company, launched a menstrual health supplement called Balance Mood Complex. This product is available as capsule and is designed to help with hormone imbalance, aiming to reduce mood swings and irritations.
• In June 2021, Power Gummies revealed the development of a formula for PMS relief that includes ingredients like chasteberry, vitamin C, passionflower, and citrus bioflavonoids. This product is gaining popularity and contributing to the growth of the PMS supplement market.

PMS & Menstrual Health Supplements Market Report Scope

Attributes	Details
Forecast Period	2024 to 2031
Historical Data Available for	2019 to 2023
Market Analysis	US$ Million for Value
Key Regions Covered	North America Europe Asia Pacific Latin America The Middle East and Africa
Key Countries Covered	The United States Canada Germany The United Kingdom France China Japan South Korea India Brazil UAE South Africa
Key Market Segments Covered	By Product Type By Formulation By Distribution Channel By Symptoms Region
Key Companies Profiled	Herbalife International of America, Inc. Pharmavite LLC Nature’s Bounty Amway; GNC Holdings Inc. USANA Health Sciences, Inc. GlaxoSmithKline Plc MetP Pharma AG RBK Nutraceuticals Pty Ltd. Archer Daniels Midland Power Gummies Looni, DM Pharma
Report Coverage	Market Forecast Company Share Analysis Competition Intelligence DROT Analysis Market Dynamics and Challenges Strategic Growth Initiatives
Customization & Pricing	Available upon request

PMS & Menstrual Health Supplements Market Segmentation

By Product

• Single Nutritional Supplements
  • Vitamins
  • Minerals
  • Herbal supplements
  • Others
• Combined Nutritional Supplements

By Consumer Group Outlook

• Premenstrual Syndrome (PMS)
• Perimenopause

By Formulation

• Capsules/Tablets
• Powder
• Softgels
• Others

By Symptom

• Bloating and Fluid Retention
• Mood Swings and Irritability
• Breast Tenderness
• Cramps and Pain
• Fatigue
• Anxiety
• Others

By Sales Channel

• Online sales channel
• Direct sales channel
• Pharmacies/Drug stores
• Other offline channels

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

About Author